Modulation of stroke risk in chronic kidney disease

Clinical Kidney Journal
Julia ArnoldCharles J Ferro

Abstract

Stroke is the second most common cause of death and the leading cause of neurological disability worldwide, with huge economic costs and tragic human consequences. Both chronic kidney disease (CKD) and end-stage kidney disease are associated with a significantly increased risk of stroke. However, to date this has generated far less interest compared with the better-recognized links between cardiac and renal disease. Common risk factors for stroke, such as hypertension, hypercholesterolaemia, smoking and atrial fibrillation, are shared with the general population but are more prevalent in renal patients. In addition, factors unique to these patients, such as disorders of mineral and bone metabolism, anaemia and its treatments as well as the process of dialysis itself, are all also postulated to further increase the risk of stroke. In the general population, advances in medical therapies mean that effective primary and secondary prevention therapies are available for many patients. The development of specialist stroke clinics and acute stroke units has also improved outcomes after a stroke. Emerging therapies such as thrombolysis and thrombectomy are showing increasingly beneficial results. However, patients with CKD and on dialy...Continue Reading

References

Sep 1, 1975·Stroke; a Journal of Cerebral Circulation
Sep 1, 1994·Stroke; a Journal of Cerebral Circulation·N A SolomonK A Schulman
Nov 25, 2000·British Medical Bulletin·C D Wolfe
Jun 16, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Kazunori ToyodaMitsuo Iida
Jul 22, 2005·The New England Journal of Medicine·Christoph WannerUNKNOWN German Diabetes and Dialysis Study Investigators
Nov 17, 2006·The New England Journal of Medicine·Tilman B DrüekeUNKNOWN CREATE Investigators
Nov 17, 2006·The New England Journal of Medicine·Ajay K SinghUNKNOWN CHOIR Investigators
Sep 20, 2007·JAMA : the Journal of the American Medical Association·Bruce F CulletonBraden J Manns
Oct 12, 2007·Lancet·Peter M RothwellUNKNOWN Early use of Existing Preventive Strategies for Stroke (EXPRESS) study
Nov 8, 2007·JAMA : the Journal of the American Medical Association·Josef CoreshAndrew S Levey
Apr 12, 2008·The New England Journal of Medicine·Hitinder S GurmUNKNOWN SAPPHIRE Investigators
Aug 9, 2008·The New England Journal of Medicine·Orlando M GutiérrezMyles Wolf
Jan 23, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Jean-Marc BugnicourtOlivier Godefroy
Apr 1, 2009·The New England Journal of Medicine·Bengt C FellströmUNKNOWN AURORA Study Group
Apr 21, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Stephen M SozioRulan S Parekh
Nov 3, 2009·The New England Journal of Medicine·Marc A PfefferUNKNOWN TREAT Investigators
Dec 1, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Varun AgrawalPeter A McCullough
Dec 17, 2009·Journal of the American Society of Nephrology : JASN·Anna MathewUNKNOWN North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators
Feb 24, 2010·Circulation·Donald Lloyd-JonesUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Apr 22, 2010·Heart·Colin D ChueCharles J Ferro
May 15, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Carmen Sánchez-PeralesAntonio Liébana
May 28, 2010·The New England Journal of Medicine·Thomas G BrottUNKNOWN CREST Investigators
Nov 26, 2010·The New England Journal of Medicine·Glenn M ChertowAlan S Kliger
Nov 26, 2010·Journal of the Neurological Sciences·Bruce Ovbiagele
Dec 24, 2010·Cerebrovascular Diseases·Nandavar ShobhaUNKNOWN Canadian Alteplase for Stroke Effectiveness Study (CASES)
Oct 14, 2011·The New England Journal of Medicine·Robert N FoleyAllan J Collins
Dec 14, 2011·Seminars in Dialysis·Jeffrey S Berns
Aug 23, 2012·Annals of Internal Medicine·Suetonia C PalmerGiovanni F M Strippoli
Sep 22, 2012·International Journal of Clinical Practice·K P NgC J Ferro

❮ Previous
Next ❯

Citations

Nov 22, 2016·JRSM Cardiovascular Disease·Ria ArnoldBruce A Pussell
Oct 19, 2019·The International Journal of Artificial Organs·Masafumi KamijoTomoya Nishino
Jan 18, 2018·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Adrian Covic, Luminita Voroneanu
Apr 22, 2018·Clinical and Experimental Nephrology·Tsang-Shan ChenChi-Chu Liu
Sep 27, 2020·The European Journal of Neuroscience·Birva ShahPallab Bhattacharya
Sep 28, 2021·International Journal of Stroke : Official Journal of the International Stroke Society·Jin Pyeong JeonChung Liang Chai

❮ Previous
Next ❯

Software Mentioned

EXTEND
ESCAPE

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.